Sunscreen Formulation and Manufacturing

The contract entails the development and production of a high-performance SPF 50 sunscreen formulated with 4.5% titanium dioxide and 4% zinc oxide as active ingredients, designed to fully comply with FDA OTC monograph standards for sun protection. The product must be hypoallergenic, oil-free, PABA-free, and biodegradable, ensuring safety for sensitive skin and environmental responsibility. Manufacturing processes must adhere to strict quality control protocols to maintain consistency, stability, and efficacy across all batches, with full documentation to support regulatory compliance and validation. Production is to be conducted under a subcontract arrangement with a designated place of performance in Melrose, Massachusetts, 02176. The solicitation, issued by the Department of Defense under the Medical Supply Chain Pharm FSA, requires responses by August 3, 2026, and falls under NAICS code 325412 for pharmaceutical and medicine manufacturing. The contract demands rigorous adherence to specifications, including ingredient purity, labeling accuracy, and compliance with U.S. regulatory frameworks, with an emphasis on reliable supply chain execution and timely delivery to fulfill defense medical needs.